PT99436A - Processo para a preparacao de derivados de amino-sulfonil-carbamatos e de com- posicoes farmaceuticas que os contem - Google Patents
Processo para a preparacao de derivados de amino-sulfonil-carbamatos e de com- posicoes farmaceuticas que os contemInfo
- Publication number
- PT99436A PT99436A PT99436A PT9943691A PT99436A PT 99436 A PT99436 A PT 99436A PT 99436 A PT99436 A PT 99436A PT 9943691 A PT9943691 A PT 9943691A PT 99436 A PT99436 A PT 99436A
- Authority
- PT
- Portugal
- Prior art keywords
- phenyl
- sulfonyl
- amino
- hydrogen
- preparation
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- WZOXJIGIDZQSDK-UHFFFAOYSA-N sulfamoylcarbamic acid Chemical class NS(=O)(=O)NC(O)=O WZOXJIGIDZQSDK-UHFFFAOYSA-N 0.000 title 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 4
- 125000004432 carbon atom Chemical group C* 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 2
- 125000000623 heterocyclic group Chemical group 0.000 abstract 2
- 125000001183 hydrocarbyl group Chemical group 0.000 abstract 2
- 125000001624 naphthyl group Chemical group 0.000 abstract 2
- 229920006395 saturated elastomer Polymers 0.000 abstract 2
- 201000001320 Atherosclerosis Diseases 0.000 abstract 1
- 208000035150 Hypercholesterolemia Diseases 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 125000002911 monocyclic heterocycle group Chemical group 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 229910052717 sulfur Chemical group 0.000 abstract 1
- 239000011593 sulfur Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/42—Radicals substituted by singly-bound nitrogen atoms having hetero atoms attached to the substituent nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C307/00—Amides of sulfuric acids, i.e. compounds having singly-bound oxygen atoms of sulfate groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C307/04—Diamides of sulfuric acids
- C07C307/06—Diamides of sulfuric acids having nitrogen atoms of the sulfamide groups bound to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C307/00—Amides of sulfuric acids, i.e. compounds having singly-bound oxygen atoms of sulfate groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C307/04—Diamides of sulfuric acids
- C07C307/08—Diamides of sulfuric acids having nitrogen atoms of the sulfamide groups bound to carbon atoms of rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C307/00—Amides of sulfuric acids, i.e. compounds having singly-bound oxygen atoms of sulfate groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C307/04—Diamides of sulfuric acids
- C07C307/10—Diamides of sulfuric acids having nitrogen atoms of the sulfamide groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/30—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
- C07D295/26—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/14—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Indole Compounds (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US61048790A | 1990-11-07 | 1990-11-07 | |
| US07/747,031 US5254715A (en) | 1990-11-07 | 1991-08-19 | Aminosulfonyl carbamates |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PT99436A true PT99436A (pt) | 1992-09-30 |
| PT99436B PT99436B (pt) | 1999-04-30 |
Family
ID=27086264
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT99436A PT99436B (pt) | 1990-11-07 | 1991-11-06 | Processo para a preparacao de derivados de amino-sulfonil-carbamatos e de com- posicoes farmaceuticas que os contem |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US5254715A (pt) |
| EP (1) | EP0592439B1 (pt) |
| JP (2) | JP3484193B2 (pt) |
| AT (1) | ATE246171T1 (pt) |
| AU (1) | AU651155B2 (pt) |
| CA (1) | CA2094807A1 (pt) |
| DE (1) | DE69133299T2 (pt) |
| DK (1) | DK0592439T3 (pt) |
| ES (1) | ES2201048T3 (pt) |
| IE (1) | IE913875A1 (pt) |
| MX (1) | MX9101957A (pt) |
| NZ (1) | NZ240480A (pt) |
| PT (1) | PT99436B (pt) |
| WO (1) | WO1992008693A1 (pt) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69508932T2 (de) * | 1994-05-04 | 1999-09-30 | Novartis Ag, Basel | N-sulfonyl- und n-sulfinylaminosäureamide als microbiozide |
| US5491170A (en) * | 1994-12-19 | 1996-02-13 | Warner-Lambert Company | β-carboxy sulfonamide ACAT inhibitors |
| US5629341A (en) * | 1995-04-12 | 1997-05-13 | The Procter & Gamble Company | Pharmaceutical composition for inhibiting the growth of viruses and cancers |
| IL117874A0 (en) | 1995-04-12 | 1996-08-04 | Procter & Gamble | Pharmaceutical compositions for inhibiting the growth of viruses and cancers |
| US6177460B1 (en) | 1995-04-12 | 2001-01-23 | The Procter & Gamble Company | Method of treatment for cancer or viral infections |
| US6686391B2 (en) | 1995-08-04 | 2004-02-03 | University Of Arizona Foundation | N-chlorophenylcarbamate and N-chlorophenylthiocarbamate compositions |
| IT1276162B1 (it) | 1995-11-23 | 1997-10-27 | Baldacci Lab Spa | Geranilgeranil-derivati,procedimento per la loro preparazione e relative composizioni farmaceutiche |
| ATE218539T1 (de) * | 1997-02-25 | 2002-06-15 | Syngenta Participations Ag | N-sulphonyl- und n-sulphinylaminosaüreamide als microbiozide |
| CA2434491A1 (en) * | 2001-01-30 | 2002-08-08 | Merck & Co., Inc. | Acyl sulfamides for treatment of obesity, diabetes and lipid disorders |
| CA2369967A1 (en) * | 2001-02-12 | 2002-08-12 | Joseph Anthony Cornicelli | Methods of treating nuclear factor-kappa b mediated diseases and disorders |
| EP1281399A3 (en) * | 2001-08-01 | 2004-02-11 | Warner-Lambert Company | Dual inhibitors of wax ester and cholesteryl ester synthesis for inhibiting sebum production |
| US7049333B2 (en) | 2002-06-04 | 2006-05-23 | Sanofi-Aventis Deutschland Gmbh | Substituted thiophenes: compositions, processes of making, and uses in disease treatment and diagnosis |
| US7202257B2 (en) | 2003-12-24 | 2007-04-10 | Deciphera Pharmaceuticals, Llc | Anti-inflammatory medicaments |
| US7144911B2 (en) | 2002-12-31 | 2006-12-05 | Deciphera Pharmaceuticals Llc | Anti-inflammatory medicaments |
| US7279576B2 (en) | 2002-12-31 | 2007-10-09 | Deciphera Pharmaceuticals, Llc | Anti-cancer medicaments |
| AU2005321946B2 (en) | 2004-12-23 | 2012-08-16 | Deciphera Pharmaceuticals, Llc | Enzyme modulators and treatments |
| US7829589B2 (en) * | 2005-06-10 | 2010-11-09 | Elixir Pharmaceuticals, Inc. | Sulfonamide compounds and uses thereof |
| JP2008545801A (ja) * | 2005-06-10 | 2008-12-18 | エリクシアー ファーマシューティカルズ， インコーポレイテッド | スルホンアミド化合物およびその使用 |
| US8188113B2 (en) | 2006-09-14 | 2012-05-29 | Deciphera Pharmaceuticals, Inc. | Dihydropyridopyrimidinyl, dihydronaphthyidinyl and related compounds useful as kinase inhibitors for the treatment of proliferative diseases |
| US7790756B2 (en) | 2006-10-11 | 2010-09-07 | Deciphera Pharmaceuticals, Llc | Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases |
| BRPI0810094A2 (pt) | 2007-04-20 | 2014-10-21 | Deciphera Pharmaceuticals Llc | Inibidores de kinase úteis para o tratamento de doenças mieloproliferativas e outras doenças proliferativas |
| AU2009308853A1 (en) | 2008-10-29 | 2010-05-06 | Deciphera Pharmaceuticals, Llc | Cyclopropane amides and analogs exhibiting anti-cancer and anti-proliferative activities |
| NZ746605A (en) | 2010-11-16 | 2020-05-29 | Texas Heart Inst | Agonists that enhance binding of integrin-expressing cells to integrin receptors |
| US8461179B1 (en) | 2012-06-07 | 2013-06-11 | Deciphera Pharmaceuticals, Llc | Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases |
| EP3746059A1 (en) | 2018-01-31 | 2020-12-09 | Deciphera Pharmaceuticals, LLC | Combination therapy for the treatment of gastrointestinal stromal tumors |
| AU2019216351B2 (en) | 2018-01-31 | 2024-07-25 | Deciphera Pharmaceuticals, Llc | Combination therapy for the treatment of mastocytosis |
| WO2021030405A1 (en) | 2019-08-12 | 2021-02-18 | Deciphera Pharmaceuticals, Llc | Ripretinib for treating gastrointestinal stromal tumors |
| CN114615982A (zh) | 2019-08-12 | 2022-06-10 | 德西费拉制药有限责任公司 | 用于治疗胃肠道间质瘤的瑞普替尼 |
| SMT202400484T1 (it) | 2019-12-30 | 2025-01-14 | Deciphera Pharmaceuticals Llc | Composizioni di 1-(4-bromo-5-(1-etil-7-(metilammino)-2-osso-1,2-diidro-1,6-naftiridin-3-il)-2-fluorofenil)-3-fenilurea |
| LT4084778T (lt) | 2019-12-30 | 2024-01-25 | Deciphera Pharmaceuticals, Llc | Amorfinės kinazės inhibitoriaus vaistinės formos ir jų panaudojimo būdai |
| US11779572B1 (en) | 2022-09-02 | 2023-10-10 | Deciphera Pharmaceuticals, Llc | Methods of treating gastrointestinal stromal tumors |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE940292C (de) * | 1952-07-01 | 1956-03-15 | Hoechst Ag | Verfahren zur Herstellung von Stickstoff und Schwefel enthaltenden Kondensationsprodukten |
| EP0123763A3 (de) * | 1983-03-30 | 1986-03-19 | Ciba-Geigy Ag | Verfahren zum Leimen von Papier mit anionischen, hydrophoben Leimungsmitteln und kationischen Retentionsmitteln |
-
1991
- 1991-08-19 US US07/747,031 patent/US5254715A/en not_active Expired - Lifetime
- 1991-11-05 CA CA002094807A patent/CA2094807A1/en not_active Abandoned
- 1991-11-05 AT AT91920248T patent/ATE246171T1/de not_active IP Right Cessation
- 1991-11-05 ES ES91920248T patent/ES2201048T3/es not_active Expired - Lifetime
- 1991-11-05 NZ NZ240480A patent/NZ240480A/en not_active IP Right Cessation
- 1991-11-05 DK DK91920248T patent/DK0592439T3/da active
- 1991-11-05 WO PCT/US1991/008215 patent/WO1992008693A1/en not_active Ceased
- 1991-11-05 AU AU89509/91A patent/AU651155B2/en not_active Ceased
- 1991-11-05 EP EP91920248A patent/EP0592439B1/en not_active Expired - Lifetime
- 1991-11-05 JP JP50093192A patent/JP3484193B2/ja not_active Expired - Fee Related
- 1991-11-05 DE DE69133299T patent/DE69133299T2/de not_active Expired - Fee Related
- 1991-11-06 MX MX9101957A patent/MX9101957A/es not_active IP Right Cessation
- 1991-11-06 PT PT99436A patent/PT99436B/pt not_active IP Right Cessation
- 1991-11-06 IE IE387591A patent/IE913875A1/en not_active Application Discontinuation
-
1993
- 1993-06-10 US US08/075,083 patent/US5336690A/en not_active Expired - Fee Related
-
2000
- 2000-06-07 JP JP2000170387A patent/JP3468738B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPH06501706A (ja) | 1994-02-24 |
| EP0592439A1 (en) | 1994-04-20 |
| US5254715A (en) | 1993-10-19 |
| US5336690A (en) | 1994-08-09 |
| DE69133299T2 (de) | 2004-01-22 |
| DE69133299D1 (de) | 2003-09-04 |
| EP0592439B1 (en) | 2003-07-30 |
| IE913875A1 (en) | 1992-05-20 |
| MX9101957A (es) | 1992-07-08 |
| JP3468738B2 (ja) | 2003-11-17 |
| AU651155B2 (en) | 1994-07-14 |
| JP2000319179A (ja) | 2000-11-21 |
| JP3484193B2 (ja) | 2004-01-06 |
| ES2201048T3 (es) | 2004-03-16 |
| NZ240480A (en) | 1994-08-26 |
| ATE246171T1 (de) | 2003-08-15 |
| DK0592439T3 (da) | 2003-11-03 |
| WO1992008693A1 (en) | 1992-05-29 |
| AU8950991A (en) | 1992-06-11 |
| CA2094807A1 (en) | 1992-05-08 |
| PT99436B (pt) | 1999-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT99436A (pt) | Processo para a preparacao de derivados de amino-sulfonil-carbamatos e de com- posicoes farmaceuticas que os contem | |
| EA199800141A1 (ru) | Гетероциклические соединения | |
| FI955438A0 (fi) | N-asyylisulfamidihappoesterit (tai -tioesterit), N-asyylisulfonamidit ja N-sulfonyylikarbamiinihappoesterit (tai -tioesterit) hyperkolesteroleemisina aineina | |
| PT96890A (pt) | Processo para a preparacao de novos derivados com estrutura naftalenica e de composicoes farmaceuticas que os contem | |
| AU5651680A (en) | Benzopyran derivatives | |
| ES525358A0 (es) | Procedimiento para la fabricacion de 4-(3-trifluorometilfenil)-1,2,3,6-tetrahidropiridinas | |
| DE69607650D1 (de) | 2,3,5-trimethyl-hydroxyanilid-derivative, ihre herstellung und ihre theraoeutische verwendung | |
| ES534959A0 (es) | Procedimiento para la preparacion de derivados de oligoglucosido | |
| ES2098023T3 (es) | Compuestos de estructura guanidinica y composiciones farmaceuticas que los contienen. | |
| PT83725B (pt) | Processo para preparacao de novos derivados da 3-oxadiol-beta-carbolina e 3-carboxilato-beta-carbolina e de composicoes farmaceuticas que os contem | |
| MX9301045A (es) | Procedimiento para preparar antagonistas receptores de fibrinogeno. | |
| DE69808099D1 (de) | Substituierte 6-alkylphenanthridine | |
| ES470745A1 (es) | Un procedimiento para preparar derivados de 6,6'-oxibis-pi- rona halo-sustituida | |
| PT99465A (pt) | Processo para preparacao de inibidores da oxisulfonil ureia acil-coa:colesterol acil-transferase (acat) | |
| BR8606955A (pt) | Processo para preparar uma composicao,concentrado aditivo,composicao lubrificante,composicao combustivel e metodo para reduzir o consumo de combustivel | |
| PT97286A (pt) | Processo para a preparacao de novos derivados do 3-aminocromano e de composicoes farmaceuticas que os contem | |
| UA7051A1 (uk) | N-[6-метоксі-5-(перфторалкін)-1-нафтоіл]-n-метілгліцин чи його тіонафтоільні аналоги як інгібітори албдозоредуктази | |
| PT99360A (pt) | Processo para a preparacao de carbamatos de oxi-sulfonilo e de composicoes farmaceuticas que os contem | |
| PT90614A (pt) | Processo para a preparacao de tienil-piperazinonas e de composicoes farmaceuticas que os contem | |
| PT99331B (pt) | Processo para a preparacao de 3-difenilmetoxi-8-azabiciclo{3.2.1}octilalquil-tiazolidinomas e de composicoes farmaceuticas que as contem | |
| PT92494A (pt) | Processo para a preparacao de novos derivados do indol | |
| DK19885A (da) | 3-alkoxy-2-(n-pyrrolidino)-n-pyridyl-n-furyl (eller thienyl)-methyl-propylaminer, fremgangsmaade til fremstilling deraf, samt farmaceutiske midler indeholdende disse | |
| AU555893B2 (en) | (1,2)-heterofused-1,4-benzodiazepine | |
| IT1191109B (it) | Derivati di acidi aminopiridincarbossilici,loro metodo di sintesi e composizioni farmaceutiche che li contengono | |
| ATE133955T1 (de) | Acylphosphatester und modifikation von proteinen damit |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BB1A | Laying open of patent application |
Effective date: 19920525 |
|
| FG3A | Patent granted, date of granting |
Effective date: 19990119 |
|
| MM3A | Annulment or lapse |
Effective date: 20060719 |